A study of the efficacy of ascidian-derived plasmalogen supplements in maintaining visual memory

Not Applicable

• Conditions: healthy adult

• Registration Number: JPRN-UMIN000041019
• Lead Sponsor: Clinical Creative Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-08-18
• Study Completion: 2020-11-14
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 146

Inclusion Criteria

Not provided

Exclusion Criteria

1.Persons taking medication for treatment of diseases (arrhythmia, liver damage, kidney damage, cerebrovascular disease, rheumatism, diabetes, dyslipidemia, hypertension and other chronic diseases) 2.Patients with malignancy, heart failure, or myocardial infarction, or who are undergoing treatment or have a history of such treatment 3.A person suffering from dementia 4.Those suffering from mental illnesses such as depression or attention deficit/hyperactivity disorder (ADHD) 5.Persons with allergies (pharmaceuticals and test foods) 6.Those who regularly consume foods or supplements that contribute to improving cognitive function, such as DHA, EPA, Ginkgo biloba extract, tocotrienol, astaxanthin, GABA, phosphatidylserine, lutein, zeaxanthin, imidazole dipeptides (carnosine, enserine, valenine), histidine, curcumin, bacopa saponin, lactonadecapeptide, anthocyanin, seryl tyrosine, auraptene, and diosgenin. 7.Persons who regularly consume pharmaceuticals (including herbal medicines), food for specified health uses, functional foods, or other foods/beverages with possible functional properties. 8.A person who has participated in another clinical trial within one month prior to obtaining consent or who is currently participating in another clinical trial. Those who, in the judgment of the principal investigator or sub-investigator, the conduct of the study may increase the risk to research subjects or may not provide sufficient data

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CogEvo

Secondary Outcome Measures

Name	Time	Method
Mini Mental State Examination